| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRI2692 |
| P698 | PubMed publication ID | 20081870 |
| P50 | author | Iain McInnes | Q41687181 |
| P2093 | author name string | Foo Y Liew | |
| Nick I Pitman | |||
| P2860 | cites work | IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 |
| IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation | Q24309034 | ||
| Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein | Q24314282 | ||
| Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket | Q24321867 | ||
| Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease | Q24631387 | ||
| HMGB1: endogenous danger signaling | Q24645232 | ||
| A novel IL-1 family cytokine, IL-33, potently activates human eosinophils | Q24647672 | ||
| The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 | Q24651453 | ||
| T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function | Q24651566 | ||
| Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules | Q24685626 | ||
| Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
| IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex | Q28239351 | ||
| Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils | Q28292740 | ||
| IL-33, a potent inducer of adaptive immunity to intestinal nematodes | Q28505946 | ||
| IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells | Q28513686 | ||
| IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system | Q28585033 | ||
| Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation | Q28586791 | ||
| IL-33 reduces the development of atherosclerosis | Q28594104 | ||
| DAMPs, PAMPs and alarmins: all we need to know about danger | Q29547535 | ||
| Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage | Q30814887 | ||
| The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? | Q33374001 | ||
| Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells | Q33508406 | ||
| The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G. | Q34166051 | ||
| Identification of serum soluble ST2 receptor as a novel heart failure biomarker | Q34176448 | ||
| Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction | Q34603397 | ||
| IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo | Q35575987 | ||
| Alarmins: chemotactic activators of immune responses | Q36162859 | ||
| Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology | Q36369101 | ||
| Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells | Q36400414 | ||
| IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice | Q36497523 | ||
| Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts | Q36796387 | ||
| IL-33 exacerbates antigen-induced arthritis by activating mast cells | Q36800502 | ||
| Induction of IL-33 expression and activity in central nervous system glia | Q36838536 | ||
| Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes | Q37000186 | ||
| Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway | Q37175226 | ||
| IL-1, IL-18, and IL-33 families of cytokines | Q37211243 | ||
| The cytokine interleukin-33 mediates anaphylactic shock | Q37238924 | ||
| Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis | Q37255168 | ||
| IL-33-activated dendritic cells induce an atypical TH2-type response | Q37265087 | ||
| Interleukin-33 is biologically active independently of caspase-1 cleavage | Q37339298 | ||
| Mature interleukin-33 is produced by calpain-mediated cleavage in vivo | Q39825950 | ||
| IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex | Q39833597 | ||
| TRAF6 is a critical signal transducer in IL-33 signaling pathway | Q39964682 | ||
| Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells | Q40049209 | ||
| Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells | Q42584586 | ||
| Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. | Q42617785 | ||
| Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. | Q42693160 | ||
| A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor | Q42834513 | ||
| Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. | Q42947124 | ||
| The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function | Q42947210 | ||
| IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals | Q43690957 | ||
| Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. | Q44030778 | ||
| Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction | Q44245130 | ||
| IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. | Q45067212 | ||
| An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor | Q46305097 | ||
| A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. | Q47310105 | ||
| Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue. | Q48075198 | ||
| The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. | Q51780702 | ||
| IL-33 is a chemoattractant for human Th2 cells. | Q53528244 | ||
| IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. | Q54421098 | ||
| Tissue Distribution and Subcellular Localization of a Variant Form of the Human ST2 Gene Product, ST2V | Q56593773 | ||
| IL-33 can promote survival, adhesion and cytokine production in human mast cells | Q57273112 | ||
| Mast cells modulate allergic pulmonary eosinophilia in mice | Q72108794 | ||
| T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation | Q80094797 | ||
| Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells | Q80736011 | ||
| Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system | Q81191920 | ||
| Elevation of ST2 protein levels in cerebrospinal fluid following subarachnoid hemorrhage | Q83185001 | ||
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Q83398961 | ||
| Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma | Q84030123 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 103-110 | |
| P577 | publication date | 2010-01-18 | |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | Disease-associated functions of IL-33: the new kid in the IL-1 family | |
| P478 | volume | 10 |
| Q33904814 | 25-Hydroxyvitamin D, IL-31, and IL-33 in children with allergic disease of the airways |
| Q37658912 | A mechanism for the induction of type 2 immune responses by a protease allergen in the genital tract |
| Q97550316 | A new dawn for eosinophils in the tumour microenvironment |
| Q39648956 | A novel method for procuring a large quantity of mature murine eosinophils in vivo |
| Q35803472 | A single-nucleotide polymorphism in the interleukin-1 receptor-associated protein gene is associated with impaired glucose regulation and type 2 diabetes in a case-controlled study |
| Q35699580 | AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites |
| Q58234722 | Ability of Interleukin-33- and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune Responses |
| Q51684114 | Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration. |
| Q36744984 | Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33. |
| Q34137362 | Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis |
| Q35631650 | Additive anti-allergic effects of anti-interleukin-33 and anti-Siglec-F treatments in a murine model of allergic asthma |
| Q92116878 | Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice |
| Q36871145 | Airway molecular endotypes of asthma: dissecting the heterogeneity |
| Q34033407 | Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity |
| Q30375869 | Alarmin IL-33 elicits potent TB-specific cell-mediated responses. |
| Q38845953 | Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses |
| Q38245926 | Allergen immunotherapy, routes of administration and cytokine networks: an update |
| Q93000694 | Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model |
| Q36445023 | Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress |
| Q33589491 | Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain |
| Q28652444 | Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33 |
| Q34895161 | Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33 |
| Q52331711 | An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. |
| Q47701304 | An Update on Host-Pathogen Interplay and Modulation of Immune Responses during Orientia tsutsugamushi Infection. |
| Q38912837 | An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis |
| Q42819258 | An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice |
| Q48283294 | Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene |
| Q38381344 | Anti-allergic properties of curine, a bisbenzylisoquinoline alkaloid. |
| Q44941485 | Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice |
| Q30415188 | Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation |
| Q90480978 | Association between interleukin-36γ and tumor progression in non-small cell lung cancer |
| Q86710783 | Association of IL33/ST2 signal pathway gene polymorphisms with myocardial infarction in a Chinese Han population |
| Q53194504 | Association of soluble ST2 with functional capacity in outpatients with heart failure. |
| Q34835415 | Associations between variants in IL-33/ST2 signaling pathway genes and coronary heart disease risk |
| Q34304314 | Basophil modulation by cytokine instruction |
| Q38830074 | Basophil-derived IL-4 plays versatile roles in immunity. |
| Q33808159 | Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation |
| Q84977996 | Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice |
| Q39465399 | Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. |
| Q42538647 | Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid Arthritis |
| Q49973003 | CD300 family receptors regulate eosinophil survival, chemotaxis, and effector functions |
| Q93261627 | Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model |
| Q38572500 | Candidate biomarkers in heart failure with reduced and preserved ejection fraction |
| Q35658781 | Cardiovascular biomarkers in acute Kawasaki disease |
| Q41464455 | Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation |
| Q34520488 | Caspase-1 regulates autoinflammation in rheumatic diseases |
| Q26748487 | Cell Culture, Technology: Enhancing the Culture of Diagnosing Human Diseases |
| Q34442444 | Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells |
| Q34155912 | Chronic low dose chlorine exposure aggravates allergic inflammation and airway hyperresponsiveness and activates inflammasome pathway |
| Q37499617 | Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling |
| Q34504507 | Chronic spontaneous urticaria and internal parasites--a systematic review. |
| Q60045482 | Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression? |
| Q38235148 | Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections |
| Q40687007 | Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis |
| Q47661265 | Comparative Study of IL-33 and IL-6 Levels in Different Respiratory Samples in Mild-to-Moderate Asthma and COPD. |
| Q34807329 | Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease |
| Q42156210 | Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature |
| Q36396910 | Computational analysis of multimorbidity between asthma, eczema and rhinitis |
| Q35886682 | Conformational Sampling and Binding Site Assessment of Suppression of Tumorigenicity 2 Ectodomain |
| Q42123554 | Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells |
| Q54213225 | Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today. |
| Q37996923 | Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma |
| Q30749968 | Cross-species evidence for the role of interleukin-33 in depression risk |
| Q35439783 | Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases |
| Q93095137 | Current perspectives on the interleukin-1 family as targets for inflammatory disease |
| Q55025675 | Cyclic AMP signaling enhances lipopolysaccharide sensitivity and interleukin-33 production in RAW264.7 macrophages. |
| Q37981059 | Cytokine pathways in allergic disease |
| Q26752374 | Cytokine-Induced Modulation of Colorectal Cancer |
| Q35861150 | Cytokine-Mediated Activation of NK Cells during Viral Infection |
| Q91636313 | Cytokines and beyond: Regulation of innate immune responses during helminth infection |
| Q35828345 | DNA methylation and childhood asthma in the inner city |
| Q37695034 | Damage-associated molecular patterns stimulate interleukin-33 expression in nasal polyp epithelial cells |
| Q38025082 | Danger signals activating the immune response after trauma |
| Q37965363 | Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm. |
| Q36994635 | Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily |
| Q52655292 | Dectin-1 stimulates IL-33 expression in dendritic cells via upregulation of IRF4. |
| Q34428400 | Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype |
| Q34121429 | Deubiquitination and stabilization of IL-33 by USP21. |
| Q41810665 | Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model. |
| Q38112683 | Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines? |
| Q34540500 | Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss |
| Q47449977 | Double-stranded RNA released from damaged articular chondrocytes promotes cartilage degeneration via Toll-like receptor 3-interleukin-33 pathway. |
| Q38956279 | Doyne lecture 2016: intraocular health and the many faces of inflammation |
| Q35904651 | Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa |
| Q37748500 | Early detection of myocardial dysfunction and heart failure |
| Q52655629 | Early-life exposure to three size-fractionated ultrafine and fine atmospheric particulates in Beijing exacerbates asthma development in mature mice. |
| Q38189119 | Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective. |
| Q37860121 | Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation: a mini-review. |
| Q92382296 | Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis |
| Q38919984 | Effects of obesity on IL-33/ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats. |
| Q37363858 | Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection |
| Q34446837 | Elevated antigen-driven IL-9 responses are prominent in peanut allergic humans |
| Q87359693 | Elevated circulating sST2 associated with subclinical atherosclerosis in newly diagnosed primary hypertension |
| Q43688310 | Elevated serum interleukin-33 levels in patients with Henoch-Schönlein purpura |
| Q38774563 | Emerging concepts: mast cell involvement in allergic diseases. |
| Q38151715 | Emerging role of interleukin-33 in autoimmune diseases |
| Q96951726 | Engineering immunomodulatory biomaterials for type 1 diabetes |
| Q36762460 | Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo |
| Q45051460 | Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation |
| Q91675729 | Epithelial barrier repair and prevention of allergy |
| Q38198788 | Epithelial function and dysfunction in asthma. |
| Q34425901 | Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma |
| Q30434426 | Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis |
| Q41019883 | Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice |
| Q41023088 | Evaluation of Anti-Inflammatory Activities of Qingre-Qushi Recipe (QRQS) against Atopic Dermatitis: Potential Mechanism of Inhibition of IL-33/ST2 Signal Transduction |
| Q36553112 | Evaluation of the circulating levels of IL-12 and IL-33 in patients with breast cancer: influences of the tumor stages and cytokine gene polymorphisms |
| Q89723039 | Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors |
| Q48120429 | Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer. |
| Q33815955 | Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells |
| Q34577102 | Exposure to cigarette smoke impacts myeloid-derived regulatory cell function and exacerbates airway hyper-responsiveness |
| Q88602737 | Exposure to low-dose bisphenol A during the juvenile period of development disrupts the immune system and aggravates allergic airway inflammation in mice |
| Q59791529 | Expression and Function of IL-33/ST2 Axis in the Central Nervous System Under Normal and Diseased Conditions |
| Q40767311 | Expression and potential roles of IL-33/ST2 in the immune regulation during Clonorchis sinensis infection |
| Q34149191 | Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis |
| Q41267861 | Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells |
| Q37608553 | Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease |
| Q94561587 | Filarial Coinfection Is Associated With Higher Bacterial Burdens and Altered Plasma Cytokine and Chemokine Responses in Tuberculous Lymphadenitis |
| Q38947692 | First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment |
| Q36054682 | Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion |
| Q39446268 | Functional interleukin-33 receptors are expressed in early progenitor stages of allergy-related granulocytes |
| Q36294725 | GATA2 is a critical transactivator for the human IL1RL1/ST2 promoter in mast cells/basophils: opposing roles for GATA2 and GATA1 in human IL1RL1/ST2 gene expression |
| Q35563351 | Genetic deletion of IL-25 (IL-17E) confers resistance to dextran sulfate sodium-induced colitis in mice |
| Q33821919 | Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis |
| Q37883044 | Genetics of interleukin 1 receptor-like 1 in immune and inflammatory diseases |
| Q34793361 | Genome-Wide Gene Expression Profiling Revealed a Critical Role for GATA3 in the Maintenance of the Th2 Cell Identity |
| Q37833146 | Genome-wide association studies for discovery of genes involved in asthma |
| Q38195863 | Genome-wide association studies of atopic dermatitis |
| Q28943402 | Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population |
| Q60907478 | Glucocorticoid Receptor Binding Inhibits an Intronic Enhancer and is Disrupted by rs4742170 (T) Allele Associated with Specific Wheezing Phenotype in Early Childhood |
| Q28395763 | Glyphosate-rich air samples induce IL-33, TSLP and generate IL-13 dependent airway inflammation |
| Q38756562 | Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications |
| Q35832735 | HPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions. |
| Q38625040 | Human Th2 but not Th9 cells release IL-31 in a STAT6/NF-κB-dependent way. |
| Q37727601 | IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism |
| Q49461527 | IL-1 family cytokines and soluble receptors in systemic lupus erythematosus |
| Q36304279 | IL-1 family cytokines trigger sterile inflammatory disease |
| Q36005876 | IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance |
| Q39402916 | IL-25 in allergic inflammation. |
| Q44983410 | IL-33 Acts to Express Schaffer Collateral/CA1 LTP and Regulate Learning and Memory by Targeting MyD88. |
| Q64100365 | IL-33 Ameliorates the Development of MSU-Induced Inflammation Through Expanding MDSCs-Like Cells |
| Q38808935 | IL-33 Effect on Quantitative Changes of CD4+CD25highFOXP3+ Regulatory T Cells in Children with Type 1 Diabetes |
| Q84698017 | IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation |
| Q41161239 | IL-33 Exacerbates Periodontal Disease through Induction of RANKL. |
| Q47351617 | IL-33 Expression in Chronic Rhinosinusitis with Nasal Polyps and Its Relationship with Clinical Severity |
| Q89659668 | IL-33 Inhibits TNF-α-Induced Osteoclastogenesis and Bone Resorption |
| Q34105719 | IL-33 Priming Enhances Peritoneal Macrophage Activity in Response to Candida albicans |
| Q64326859 | IL-33 Promotes the Development of Colorectal Cancer Through Inducing Tumor-Infiltrating ST2L Regulatory T Cells in Mice |
| Q27315329 | IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline. |
| Q38005217 | IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology |
| Q93060094 | IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming |
| Q60812017 | IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors |
| Q92277121 | IL-33 and its increased serum levels as an alarmin for imminent pulmonary complications in polytraumatized patients |
| Q46324957 | IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. |
| Q34606519 | IL-33 attenuates anoxia/reoxygenation-induced cardiomyocyte apoptosis by inhibition of PKCβ/JNK pathway |
| Q35665373 | IL-33 attenuates the development of experimental autoimmune uveitis. |
| Q50787510 | IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo. |
| Q40265668 | IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. |
| Q47718005 | IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer |
| Q57053348 | IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells |
| Q35758456 | IL-33 exacerbates acute kidney injury |
| Q35402371 | IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. |
| Q48449404 | IL-33 expression in the cerebral cortex following experimental subarachnoid hemorrhage in rats |
| Q58770481 | IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE |
| Q36050546 | IL-33 family members and asthma - bridging innate and adaptive immune responses. |
| Q90013907 | IL-33 in Tumor Immunity: Nothing to Sneeze At |
| Q37417506 | IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function |
| Q33963816 | IL-33 induces IL-9 production in human CD4+ T cells and basophils |
| Q36514301 | IL-33 induces a hyporesponsive phenotype in human and mouse mast cells. |
| Q46504021 | IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice |
| Q34276672 | IL-33 is a crucial amplifier of innate rather than acquired immunity |
| Q34289318 | IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells |
| Q33740028 | IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects. |
| Q24633495 | IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G |
| Q42935119 | IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. |
| Q55405080 | IL-33 notably inhibits the growth of colon cancer cells. |
| Q39439468 | IL-33 polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in a birth cohort |
| Q36082314 | IL-33 promotes MHC class II expression in murine mast cells |
| Q38775054 | IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis |
| Q41842923 | IL-33 released by alum is responsible for early cytokine production and has adjuvant properties |
| Q36040193 | IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms |
| Q26700067 | IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system |
| Q59808873 | IL-33 suppresses GSK-3β activation through an ST2-independent MyD88/TRAF6/RIP/PI3K/Akt pathway |
| Q41965694 | IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells |
| Q33830896 | IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice. |
| Q35946057 | IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice |
| Q36793403 | IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling. |
| Q36593464 | IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent |
| Q35557167 | IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells |
| Q33738493 | IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps |
| Q37990785 | IL-33/ST2 axis in inflammation and immunopathology. |
| Q42204336 | IL-33/ST2 axis in innate and acquired immunity to tumors. |
| Q33925929 | IL-33/ST2 axis promotes mast cell survival via BCLXL. |
| Q35058035 | IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells |
| Q39529075 | IL-33/ST2 involves the immunopathology of ocular toxoplasmosis in murine model |
| Q33779103 | IL-33/ST2-mediated inflammation in macrophages is directly abrogated by IL-10 during rheumatoid arthritis. |
| Q88723199 | IL-33/s-ST2 ratio, systemic symptoms, and basophil activation in Pru p 3-sensitized allergic patients |
| Q36960477 | IL-33: a novel danger signal system in atopic dermatitis |
| Q40305455 | IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population |
| Q38828462 | IL33 in rheumatoid arthritis: potencial contribution to pathogenesis |
| Q35142807 | Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma |
| Q35565839 | Identification of potential small molecule allosteric modulator sites on IL-1R1 ectodomain using accelerated conformational sampling method |
| Q44056900 | IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation. |
| Q36125752 | Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease |
| Q38181015 | Immunobiology of critical pediatric asthma |
| Q91892681 | Immunomodulatory role of Interleukin-33 in large vessel vasculitis |
| Q38085051 | Immunopathogenesis of allergic disorders: current concepts |
| Q37982064 | Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus |
| Q36807908 | Implications for Interleukin-33 in solid organ transplantation |
| Q60046874 | Increased Expression of sST2 in Early HIV Infected Patients Attenuated the IL-33 Induced T Cell Responses |
| Q38830215 | Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies. |
| Q41958860 | Increased interleukin 33 in patients with neuro-Behcet's disease: correlation with MCP-1 and IP-10 chemokines |
| Q38159446 | Indication of immune activation in patients with perceived food hypersensitivity |
| Q37641240 | Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells |
| Q34299338 | Inflammasomes in neuroinflammation and changes in brain function: a focused review |
| Q34358060 | Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. |
| Q34549969 | Inflammatory mechanisms in tendinopathy - towards translation |
| Q38627886 | Influence of IL-6, IL-33, and TNF-α on human mast cell activation: Lessons from single cell analysis by flow cytometry |
| Q28396866 | Inhalation of rod-like carbon nanotubes causes unconventional allergic airway inflammation |
| Q50087583 | Injury, repair, inflammation and metaplasia in the stomach. |
| Q38007827 | Innate and adaptive immune responses in asthma |
| Q39402938 | Innate and adaptive type 2 immunity in lung allergic inflammation. |
| Q36074379 | Innate immunological function of TH2 cells in vivo. |
| Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
| Q38325566 | Innate lymphoid cells involve in tumorigenesis. |
| Q35634065 | Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. |
| Q45365691 | Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax |
| Q55275991 | Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma. |
| Q41499755 | Intelectin contributes to allergen-induced IL-25, IL-33, and TSLP expression and type 2 response in asthma and atopic dermatitis |
| Q50320993 | Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E. |
| Q38702558 | Interleukin 33 is a guardian of barriers and a local alarmin |
| Q33987547 | Interleukin 33: a switch-hitting cytokine |
| Q55340253 | Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis. |
| Q38443719 | Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma |
| Q91656184 | Interleukin-33 (IL-33) Increases Hyperoxia-Induced Bronchopulmonary Dysplasia in Newborn Mice by Regulation of Inflammatory Mediators |
| Q60046076 | Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production |
| Q40889691 | Interleukin-33 Expression Indicates a Favorable Prognosis in Malignant Salivary Gland Tumors |
| Q54967737 | Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis. |
| Q36228512 | Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis |
| Q59351894 | Interleukin-33 and ST2 Signaling in Tumor Microenvironment |
| Q38859663 | Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases |
| Q42181941 | Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma |
| Q46419763 | Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells |
| Q52678075 | Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells. |
| Q36751804 | Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer. |
| Q51071343 | Interleukin-33 exacerbates acute colitis via interleukin-4 in mice. |
| Q59333251 | Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis |
| Q36585708 | Interleukin-33 in the human placenta |
| Q38753216 | Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy |
| Q35105619 | Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin |
| Q47377251 | Interleukin-33 modulates the expression of human β-defensin 2 in human primary keratinocytes and may influence the susceptibility to bacterial superinfection in acute atopic dermatitis |
| Q37596499 | Interleukin-33 potentiates bleomycin-induced lung injury |
| Q34448122 | Interleukin-33 primes mast cells for activation by IgG immune complexes |
| Q50515474 | Interleukin-33 prolongs allograft survival during chronic cardiac rejection. |
| Q40972417 | Interleukin-33 promotes Th2 immune responses in infected mice with Schistosoma japonicum |
| Q64104235 | Interleukin-33 regulates hematopoietic stem cell regeneration after radiation injury |
| Q33678403 | Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease |
| Q39324207 | Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye. |
| Q39209203 | Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation |
| Q64132725 | Interleukin-33 safeguards neutrophils in sepsis |
| Q45317118 | Interleukin-33 signaling |
| Q35785935 | Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. |
| Q41945735 | Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis |
| Q39084378 | Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells |
| Q89481704 | Interleukin-33: Its Emerging Role in Allergic Diseases |
| Q91640755 | International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants: Impact of air pollution on patients with AR: Current knowledge and future strategies |
| Q38417709 | Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth. |
| Q28397819 | Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis |
| Q48272507 | Investigating the role of IL-33 in the pathogenesis of Behçet's Disease |
| Q39032113 | Involvement of ERK and p38 MAPK pathways on Interleukin-33-induced RANKL expression in osteoblastic cells |
| Q39455563 | Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α-Dependent miR-155 Suppression. |
| Q41437208 | Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow |
| Q37123845 | Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. |
| Q60301285 | Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS |
| Q85224339 | Loss of Suppression of Tumorigenicity 2 (ST2) Gene Reverses Sepsis-induced Inhibition of Lung Host Defense in Mice |
| Q51491152 | Low-dose benzo[a]pyrene aggravates allergic airway inflammation in mice. |
| Q36991150 | Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production |
| Q54314108 | Lysosome biogenesis regulated by the amino-acid transporter SLC15A4 is critical for functional integrity of mast cells. |
| Q37609295 | M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection. |
| Q34639723 | Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity |
| Q38008374 | Mast Cells Respond to Cell Injury through the Recognition of IL-33. |
| Q26824984 | Mast cell activation: a complex interplay of positive and negative signaling pathways |
| Q35077675 | Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms |
| Q84742904 | Mast cells |
| Q35211917 | Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis |
| Q59271653 | Mechanisms of allergen-specific immunotherapy |
| Q33797551 | Mechanisms of smooth muscle responses to inflammation |
| Q37509047 | Mechanisms of tolerance and allergic sensitization in the airways and the lungs. |
| Q85544032 | Membrane microdomain organization, calcium signal, and NFAT activation as an important axis in polarized Th cell function |
| Q28260209 | MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease |
| Q58316591 | Molecular Definition of Inflammasomes |
| Q35988587 | Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model |
| Q28391783 | Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice |
| Q37617670 | Murine mast cells secrete and respond to interleukin-33 |
| Q35880106 | Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation |
| Q92072341 | Negative Association of Interleukin-33 Plasma Levels and Schistosomiasis Infection in a Site of Polyparasitism in Rural Cameroon |
| Q47893052 | Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons |
| Q37345931 | Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice |
| Q57289127 | New Cytokines in the Pathogenesis of Atopic Dermatitis-New Therapeutic Targets |
| Q37847502 | New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? |
| Q64883707 | Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides - The Case for Soluble ST2. |
| Q35191071 | Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation |
| Q38033164 | Novel identified receptors on mast cells |
| Q38056157 | Novel insights into mechanisms of food allergy and allergic airway inflammation using experimental mouse models |
| Q38038253 | Ocular manifestations of the autoinflammatory syndromes |
| Q91811754 | Oncostatin M in the Regulation of Connective Tissue Cells and Macrophages in Pulmonary Disease |
| Q91587353 | Oral exposure to low dose bisphenol A aggravates allergic airway inflammation in mice |
| Q42937988 | Osteoblast Hypoxia-Inducible Factor-1α Pathway Activation Restrains Osteoclastogenesis via the Interleukin-33-MicroRNA-34a-Notch1 Pathway |
| Q52141871 | Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma. |
| Q28505577 | Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation |
| Q54433261 | Patch testing of food allergens promotes Th17 and Th2 responses with increased IL-33: a pilot study. |
| Q34994590 | Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis |
| Q34073302 | Pathophysiology of cisplatin-induced acute kidney injury |
| Q37117633 | Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD. |
| Q36082339 | Peripheral basophil reactivity, CD203c expression by Cryj1 stimulation, is useful for diagnosing seasonal allergic rhinitis by Japanese cedar pollen |
| Q98730943 | Peripheral levels of sST2 are increased in patients with temporal lobe epilepsy: Additional evidence of low-grade inflammation |
| Q90398115 | Pilot-Scale Study Of Human Plasma Proteomics Identifies ApoE And IL33 As Markers In Atopic Asthma |
| Q38907279 | Plasma IL-33 in atopic patients correlates with pro-inflammatory cytokines and changes cholesterol transport protein expression: a surprising neutral overall impact on atherogenicity |
| Q87454549 | Plasma soluble ST2 levels correlate with disease severity and predict clinical worsening in patients with pulmonary arterial hypertension |
| Q35841095 | Polymorphisms of ST2-IL18R1-IL18RAP gene cluster: a new risk for autoimmune thyroid diseases. |
| Q37706803 | Positive selection of IL-33 in adaptive immunity of domestic Chinese goats. |
| Q36539857 | Potential effector and immunoregulatory functions of mast cells in mucosal immunity |
| Q54960727 | Potential role of the IL-33/ST2 axis in celiac disease. |
| Q48319320 | Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury. |
| Q47387189 | Predictive value of serum sST2 in preschool wheezers for development of asthma with high FeNO. |
| Q39406925 | Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden |
| Q47101543 | Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure |
| Q47992175 | Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria |
| Q37730806 | Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy |
| Q38793189 | Protection against oxidative stress by vitamin D in cone cells |
| Q41331530 | Protocadherin-1 binds to SMAD3 and suppresses TGF-β1-induced gene transcription |
| Q38040602 | Recent developments in basophil research: do basophils initiate and perpetuate type 2 T-helper cell responses?. |
| Q42607304 | Reduced IL-33 plasma levels in aplastic anemia |
| Q54535403 | Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus. |
| Q38742473 | Regulation of IL-33 by Oncostatin M in Mouse Lung Epithelial Cells. |
| Q36056528 | Regulation of innate CD8+ T-cell activation mediated by cytokines |
| Q36092456 | Regulation of mast cell responses in health and disease |
| Q26752524 | Regulatory Role of IL-1R8 in Immunity and Disease |
| Q38003474 | Regulatory cells in allergen-specific immunotherapy |
| Q35810246 | Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33. |
| Q37829145 | Respiratory and gastrointestinal epithelial modulation of the immune response during viral infection. |
| Q41145879 | Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33. |
| Q39017773 | Role of Anti-inflammatory Cytokines IL-35 and IL-37 in Asthma |
| Q37126011 | Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system. |
| Q38195380 | Role of interleukin 33 in respiratory allergy and asthma. |
| Q37620811 | Role of the IL-33-ST2 axis in sepsis |
| Q64102858 | Role of the IL-33/ST2/p38 signaling pathway in the immune response of corneal epithelial cells to infection |
| Q26747318 | Roles of IL-33 in Resistance and Tolerance to Systemic Candida albicans Infections |
| Q28740320 | ST2 and IL-33 in pregnancy and pre-eclampsia |
| Q37101727 | ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma |
| Q36028908 | ST2L Transmembrane Receptor Expression: An Immunochemical Study on Endarterectomy Samples |
| Q35075328 | Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis |
| Q33901176 | Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice. |
| Q37284292 | Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke |
| Q36004251 | Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B |
| Q35725505 | Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C |
| Q37498738 | Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis |
| Q37430618 | Serum Levels of Soluble ST2 and IL-10 Are Associated with Disease Severity in Patients with IgA Nephropathy |
| Q28239055 | Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway |
| Q35122488 | Serum soluble ST2 is associated with ER-positive breast cancer |
| Q53154978 | Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. |
| Q36240848 | Signal transduction and chemotaxis in mast cells |
| Q37700227 | Significance of interleukin-33 and its related cytokines in patients with breast cancers |
| Q37439634 | Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment |
| Q37229321 | Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically |
| Q45870185 | Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females |
| Q36144350 | Sterile inflammation - do innate lymphoid cell subsets play a role? |
| Q48009734 | Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes. |
| Q27679811 | Structural insights into the interaction of IL-33 with its receptors |
| Q57049900 | Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin |
| Q84930428 | Successfully mapping novel asthma loci by GWAS |
| Q42375854 | TCR-independent functions of Th17 cells mediated by the synergistic actions of cytokines of the IL-12 and IL-1 families. |
| Q35972372 | TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair |
| Q47596055 | Targeting IL-33/ST2 signaling: regulation of immune function and analgesia |
| Q38057796 | Th2 cytokine antagonists: potential treatments for severe asthma |
| Q89482967 | The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers |
| Q36324815 | The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33. |
| Q89551931 | The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function |
| Q35665034 | The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution |
| Q41961424 | The GOLD domain-containing protein TMED1 is involved in interleukin-33 signaling. |
| Q37217084 | The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population |
| Q94503619 | The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications |
| Q35607302 | The IL-33/ST2 axis augments effector T-cell responses during acute GVHD. |
| Q37174541 | The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani |
| Q36597522 | The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice |
| Q41948431 | The Other T Helper Cells in Asthma Pathogenesis |
| Q59138410 | The Risk G Allele of the Single-Nucleotide Polymorphism rs928413 Creates a CREB1-Binding Site That Activates Promoter in Lung Epithelial Cells |
| Q51308719 | The Role of IL-33 on LPS-Induced Acute Lung Injury in Mice. |
| Q37571181 | The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment. |
| Q58756972 | The Role of IL-33/ST2 Pathway in Tumorigenesis |
| Q33593742 | The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases |
| Q38131032 | The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus. |
| Q34708854 | The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses |
| Q38967737 | The epithelial barrier and immunoglobulin A system in allergy |
| Q38071241 | The evolutionary role of the IL-33/ST2 system in host immune defence |
| Q47414882 | The full-length interleukin-33 (FLIL33)-importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation. |
| Q34391415 | The interleukin-1 family: back to the future |
| Q37766451 | The many paths to asthma: phenotype shaped by innate and adaptive immunity |
| Q34590317 | The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice |
| Q38424483 | The potential role of IL-33/ST2 signaling in fibrotic diseases |
| Q54330061 | The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. |
| Q26783420 | The role of IL-33 and mast cells in allergy and inflammation |
| Q46317388 | The variations in the IL1RL1 gene and susceptibility to preeclampsia |
| Q40942192 | Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation |
| Q30418533 | Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists |
| Q53126993 | Tumor necrosis factor-α regulates interleukin-33 expression through extracellular signal-regulated kinase, p38, and nuclear factor-κB pathways in airway epithelial cells. |
| Q34749359 | Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells |
| Q47285918 | Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8. |
| Q58104422 | Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression |
| Q38064849 | Type 2 innate lymphoid cells: friends or foes-role in airway allergic inflammation and asthma |
| Q27004109 | Understanding the role of antibodies in murine infections with Heligmosomoides (polygyrus) bakeri: 35 years ago, now and 35 years ahead |
| Q33855694 | Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis |
| Q38755493 | Vascularized composite allograft-specific characteristics of immune responses |
| Q92874729 | Vitamin D Attenuates Oxidative Damage and Inflammation in Retinal Pigment Epithelial Cells |
| Q43173595 | Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33. |
| Q37842638 | What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? |
| Q37798030 | What's new in asthma pathophysiology and immunopathology? |
| Q41612970 | miR-487b mitigates chronic heart failure through inhibition of the IL-33/ST2 signaling pathway |
| Q89900327 | p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells |
Search more.